MLAB Biosciences
Pre-clinicalMLAB Biosciences is a biotechnology company that leverages its proprietary DIRECT™ platform to discover and develop novel antibody-based therapies for muscular dystrophies and other unmet medical needs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.5M
About
MLAB Biosciences is a biotechnology company that leverages its proprietary DIRECT™ platform to discover and develop novel antibody-based therapies for muscular dystrophies and other unmet medical needs.
Biologics
Funding History
1Total raised:$2.5M
Seed$2.5MAug 15, 2021